HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Carrasco-Hernández Selected Research

icenticaftor

10/2021Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laura Carrasco-Hernández Research Topics

Disease

4Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2017
2Bronchiectasis
01/2022 - 01/2019
1Chronic Bronchitis
01/2022
1Cystic Fibrosis (Mucoviscidosis)
01/2019

Drug/Important Bio-Agent (IBA)

1Interleukin-8 (Interleukin 8)IBA
01/2022
1Protein SIBA
10/2021
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
10/2021
1ivacaftorIBA
10/2021
1icenticaftorIBA
10/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Muscarinic AntagonistsIBA
01/2017
1Bronchodilator Agents (Bronchodilators)IBA
01/2017

Therapy/Procedure

2Therapeutics
04/2020 - 01/2019
1Nebulizers and Vaporizers (Inhaler)
01/2017